Infiltrating mast cells correlate with angiogenesis in bone metastases from gastric cancer patients

International Journal of Molecular Sciences

Volumn 16, Issue 2, 2015, Pages 3237-3250

  Ammendola, Michele ^a,b   Marech, Ilaria ^b   Sammarco, Giuseppe ^a   Zuccalà, Valeria ^a   Luposella, Maria ^a   Zizzo, Nicola ^c   Patruno, Rosa ^c   Crovace, Alberto ^c   Ruggieri, Eustachio ^b   Francesco Zito, Alfredo ^d   Gadaleta, Cosmo Damiano ^b   Sacco, Rosario ^a   Ranieri, Girolamo ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d ASL BA   (Italy)

Author keywords

Anti angiogenetic therapy; Bone metastases; Gastric cancer; Mast cells; Tryptase

Indexed keywords

CD31 ANTIGEN; MONOCLONAL ANTIBODY; TRYPTASE;

ADULT; AGED; ANGIOGENESIS; ANTIANGIOGENIC THERAPY; ARTICLE; BONE MARROW BIOPSY; BONE METASTASIS; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CANCER TISSUE; CELL DENSITY; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; MAST CELL; MICROSCOPY; MICROVASCULAR DENSITY; MORPHOMETRICS; NEOVASCULARIZATION (PATHOLOGY); OSTEOCLAST ACTIVITY; RETROSPECTIVE STUDY; STOMACH CANCER; TUMOR LOCALIZATION; TUMOR MICROENVIRONMENT; BONE TUMOR; CANCER GRADING; CELL COUNT; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; SECONDARY; STOMACH TUMOR; TUMOR VOLUME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CELL COUNT; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAST CELLS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; STOMACH NEOPLASMS; TUMOR BURDEN;

EID: 84961291924     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms16023237     Document Type: Article

References (45)

1. Kim, H.S.; Yi, S.Y.; Jun, H.J.; Lee, J.; Park, J.O.; Park, Y.S.; Jang, J.; Kim, H.J.; Ko, Y.; Lim, H.Y. et al. Clinical outcome of gastric cancer patients with bone marrow metastases. Oncology 2007, 73, 192–197.
2. Ekinci, A.S.; Bal, O.; Ozatli, T.; Türker, I.; Eşbah, O.; Demirci, A.; Budakoğlu, B.; Arslan, U.Y.; Eraslan, E.; Oksüzoğlu, B. Gastric carcinoma with bone marrow metastasis: A case series. J. Gastric Cancer 2014, 14, 54–57.
3. Park, E.H.; Kim, Y.J.; Yamabe, N.; Park, S.H.; Kim, H.K.; Jang, H.J.; Kim, J.H.; Cheon, G.J.; Ham, J.; Kang, K.S. Stereospecific anticancer effects of ginsenoside Rg3 epimers isolated from heat-processed American ginseng on human gastric cancer cell. J. Ginseng Res. 2014, 38, 22–27.
4. Lazar, D.; Raica, M.; Sporea, I.; Tăban, S.; Goldiş, A.; Cornianu, M. Tumor angiogenesis in gastric cancer. Rom. J. Morphol. Embryol. 2006, 47, 5–13.
5. Ribatti, D.; Guidolin, D.; Marzullo, A.; Nico, B.; Annese, T.; Benagiano, V.; Crivellato, E. Mast cells and angiogenesis in gastric carcinoma. Int. J. Exp. Pathol. 2010, 91, 350–356.
6. Irani, A.M.; Schwartz, L.B. Human mast cell heterogeneity. Allergy Proc. 1994, 15, 303–308.
7. Marech, I.; Ammendola, M.; Gadaleta, C.; Zizzo, N.; Oakley, C.; Gadaleta, C.D.; Ranieri, G. Possible biological and translational significance of mast cells density in colorectal cancer. World J. Gastroenterol. 2014, 20, 8910–8920.
8. Marshall, J.S. Mast-cell responses to pathogens. Nat. Rev. Immunol. 2004, 4, 787–799.
9. Hassan, S.; Kinoshita, Y.; Kawanami, C.; Kishi, K.; Matsushima, Y.; Ohashi, A.; Funasaka, Y.; Okada, A.; Maekawa, T.; He-Yao, W. et al. Expression of protooncogene c-Kit and its ligand stem cell factor (SCF) in gastric carcinoma cell lines. Dig. Dis. Sci. 1998, 43, 8–14.
10. Ribatti, D.; Ranieri, G.; Basile, A.; Azzariti, A.; Paradiso, A.; Vacca, A. Tumor endothelial markers as a target in cancer. Expert Opin. Ther. Targets 2012, 16, 1215–1225.
11. Marech, I.; Patruno, R.; Zizzo, N.; Gadaleta, C.; Introna, M.; Zito, A.F.; Gadaleta, C.D.; Ranieri, G. Masitinib (AB1010), from canine tumor model to human clinical development: Where we are? Crit. Rev. Oncol. Hematol. 2014, 91, 98–11.
12. Ammendola, M.; Sacco, R.; Donato, G.; Zuccalà, V.; Russo, E.; Luposella, M.; Vescio, G.; Rizzuto, A.; Patruno, R.; de Sarro, G. et al. Mast cell positivity to tryptase correlates with metastatic lymph nodes in gastrointestinal cancer patients treated surgically. Oncology 2013, 85, 111–116.
13. Starkey, J.R.; Crowle, P.K.; Taubenberger, S. Mast-cell-deficient W/Wv mice exhibit a decreased rate of tumor angiogenesis. Int. J. Cancer 1988, 42, 48–52.
14. Ammendola, M.; Leporini, C.; Marech, I.; Gadaleta, C.D.; Scognamillo, G.; Sacco, R.; Sammarco, G.; de Sarro, G.; Russo, E.; Ranieri, G. Targeting mast cells tryptase in tumor microenvironment: A potential antiangiogenetic strategy. Biomed. Res. Int. 2014, 2014, 154702.
15. Marech, I.; Ammendola, M.; Sacco, R.; Capriuolo, G.S.; Patruno, R.; Rubini, R.; Luposella, M.; Zuccalà, V.; Savino, E.; Gadaleta, C.D. et al. Serum tryptase, mast cells positive to tryptase and microvascular density evaluation in early breast cancer patients: Possible translational significance. BMC Cancer 2014, 14, 534.
16. Marech, I.; Gadaleta, C.D.; Ranieri, G. Possible prognostic and therapeutic significance of c-Kit expression, mast cell count and microvessel density in renal cell carcinoma. Int. J. Mol. Sci. 2014, 15, 13060–13076.
17. Ammendola, M.; Sacco, R.; Sammarco, G.; Donato, G.; Montemurro, S.; Ruggieri, E.; Patruno, R.; Marech, I.; Cariello, M.; Vacca, A. et al. Correlation between serum tryptase, mast cells positive to tryptase and microvascular density in colo-rectal cancer patients: Possible biological-clinical significance. PLoS One 2014, 9, e99512.
18. Ammendola, M.; Sacco, R.; Sammarco, G.; Donato, G.; Zuccalà, V.; Luposella, M.; Patruno, R.; Marech, I.; Montemurro, S.; Zizzo, N. et al. Mast cells density positive to tryptase correlates with angiogenesis in pancreatic ductal adenocarcinoma patients having undergone surgery. Gastroenterol. Res. Pract. 2014, 11, 951957.
19. Patruno, R.; Marech, I.; Zizzo, N.; Ammendola, M.; Nardulli, P.; Gadaleta, C.; Introna, M.; Capriuolo, G.; Rubini, R.A.; Ribatti, D. et al. C-Kit expression, angiogenesis, and grading in canine mast cell tumour: A unique model to study c-Kit driven human malignancies. Biomed. Res. Int. 2014, 2014, 730246.
20. Mangia, A.; Malfettone, A.; Rossi, R.; Paradiso, A.; Ranieri, G.; Simone, G.; Resta, L. Tissue remodelling in breast cancer: Human mast cell tryptase as an initiator of myofibroblast differentiation. Histopathology 2011, 58, 1096–1106.
21. Ranieri, G.; Labriola, A.; Achille, G.; Florio, G.; Zito, A.F.; Grammatica, L.; Paradiso, A. Microvessel density, mast cell density and thymidine phosphorylase expression in oral squamous carcinoma. Int. J. Oncol. 2002, 21, 1317–1323.
22. Malfettone, A.; Silvestris, N.; Saponaro, C.; Ranieri, G.; Russo, A.; Caruso, S.; Popescu, O.; Simone, G.; Paradiso, A.; Mangia, A. High density of tryptase-posit ive mast cells in human colorectal cancer: A poor prognostic factor related to protease-activated receptor 2 expression. J. Cell. Mol. Med. 2013, 17, 1025–1037.
23. Ranieri, G. Hot topic: Targeting tumor angiogenesis: An update. Curr. Med. Chem. 2012, 9, 937.
24. Ranieri, G.; Passantino, L.; Patruno, R.; Passantino, G.; Jirillo, F.; Catino, A.; Mattioli, V.; Gadaleta, C.; Ribatti, D. The dog mast cell tumour as a model to study the relationship between angiogenesis, mast cell density and tumour malignancy. Oncol. Rep. 2005, 5, 1189–1193.
25. Ranieri, G.; Patruno, R.; Lionetti, A.; di Summa, A.; Mattioli, E.; Bufo, P.; Pellecchia, A.; Ribatti, D.; Zizzo, N. Endothelial area and microvascular density in a canine non-Hodgkin’s lymphoma: An interspecies model of tumor angiogenesis. Leuk. Lymphoma 2005, 46, 1639–1643.
26. Zizzo, N.; Patruno, R.; Zito, F.A.; di Summa, A.; Mattioli, E.; Bufo, P.; Pellecchia, A.; Ribatti, D.; Zizzo, N. Vascular endothelial growth factor concentrations from platelets correlate with tumor angiogenesis and grading in a spontaneous canine non-Hodgkin lymphoma model. Leuk. Lymphoma 2010, 51, 291–296.
27. Gulubova, M.; Vlaykova, T. Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer. J. Gastroenterol. Hepatol. 2009, 24, 1265–1275.
28. Nakae, S.; Suto, H.; Kakurai, M.; Sedgwick, J.D.; Tsai, M.; Galli, S.J. Mast cells enhance T cell activation: Importance of mast cell-derived TNF. Proc. Natl. Acad. Sci. USA 2005, 102, 6467–6472.
29. Ribatti, D.; Ranieri, G.; Nico, B.; Benagiano, V.; Crivellato, E. Tryptase and chymase are angiogenic in vivo in the chorioallantoic membrane assay. Int. J. Dev. Biol. 2011, 55, 99–102.
30. Blair, R.J.; Meng, H.; Marchese, M.J.; Ren, S.; Schwartz, L.B.; Tonnesen, M.G.; Gruber, B.L. Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor. J. Clin. Investig. 1997, 99, 2691–2700.
31. Morris, D.R.; Ding, Y.; Ricks, T.K.; Gullapalli, A.; Wolfe, B.L.; Trejo, J. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells. Cancer Res. 2006, 66, 307–314.
32. Khazaie, K.; Blatner, N.R.; Khan, M.W.; Gounari, F.; Gounaris, E.; Dennis, K.; Bonertz, A.; Tsai, F.N.; Strouch, M.J.; Cheon, E. et al. The significant role of mast cells in cancer. Cancer Metastasis Rev. 2011, 30, 45–60.
33. Taipale, J.; Lohi, J; Saarinen, J.; Kovanen, P.T.; Keski-Oja, J. Human mast cell chymase and leukocyte elastase release latent transforming growthfactor-β1 from the extracellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem. 1995, 270, 4689–4696.
34. Gruber, B. L.; Marchese, M. J.; Suzuki, K.; Schwartz, L.B.; Okada, Y.; Nagase, H.; Ramamurthy, N.S. Synovial procollagenase activation by human mast cell tryptase dependence up on matrixmetallo-proteinase 3 activation. J. Clin. Investig. 1989, 84, 1657–1662.
35. Stack, M.S.; Johnson, D.A. Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase), J. Biol. Chem. 1994, 269, 9416–9419.
36. Ribatti, D.; Ennas, M. G.; Vacca, A.; Ferreli, F.; Nico, B.; Orru, S.; Sirigu, P. Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur. J. Clin. Investig. 2003, 33, 420–425.
37. Benitez-Bribiesca, L.; Wong, A.; Utrera, D.; Castellanos, E. The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J. Histochem. Cytochem. 2001, 49, 1061–1062.
38. Ammendola, M.; Sacco, R.; Sammarco, G.; Donato, G.; Zuccalà, V.; Romano, R.; Luposella, M.; Patruno, R.; Vallicelli, C.; Verdecchia, G.M. et al. Mast cells positive to tryptase and c-Kit receptor expressing cells correlates with angiogenesis in gastric cancer patients surgically treated. Gastroenterol. Res. Pract. 2013, 2013, 703163.
39. Acikalin, M.F.; Oner, U.; Topcu, I.; Yasar, B.; Kiper, H.; Colak, E. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas, Dig. Liver Dis. 2005, 37, 162–169.
40. Kakeji, Y.; Maehara, Y.; Sumiyoshi, Y.; Oda, O.; Emi, Y. Angiogenesis as a target for gastric cancer. Surgery 2002, 131, S48–S54.
41. Kakeji, Y.; Koga, T.; Sumiyoshi, Y.; Shibahara, K.; Oda, S.; Maehara, Y.; Sugimachi, K. Clinical significance of vascular endothelial growth factor expression in gastric cancer. J. Exp. Clin. Cancer Res. 2002, 21, 125–129.
42. Mukherjee, S.; Bandyopadhyay, G.; Dutta, D.; Bhattacharya, A.; Karmakar, R.; Barui, G. Evaluation of endoscopic biopsy in gastric lesions with a special reference to the significance of mast cell density. Indian J. Pathol. Microbiol. 2009, 52, 20–24.
43. D’Amico, L.; Satolli, M.A.; Mecca, C.; Castiglione, A.; Ceccarelli, M.; D'Amelio, P.; Garino, M.; De Giuli, M.; Sandrucci, S.; Ferracini, R. et al. Bone metastases in gastric cancer follow a RANKL-independent mechanism. Oncol. Rep. 2013, 29, 1453–1458.
44. Galli, S.J.; Nakae, S.; Tsai, M. Mast cells in the development of adaptive immune responses. Nat. Immunol. 2005, 6, 135–142.
45. Silvestris, N.; Pantano, F.; Ibrahim, T.; Gamucci, T.; de Vita, F.; di Palma, T.; Pedrazzoli, P.; Barni, S.; Bernardo, A.; Febbraro, A. et al. Natural history of malignant bone disease in gastric cancer: Final results of a multicenter bone metastasis survey. PLoS One 2013, 28, e74402.